Natural progression of cardiac autonomic neuropathy in patients with type 1 diabetes: A four-year follow-up study;Tip 1 diyabetli hastalarda kardiyak otonom nöropatinin doǧal gidişi: Dört yıllık takip çalışması

Anadolu Kardiyoloji Dergisi

Volumn 11, Issue 3, 2011, Pages 224-231

  Abd El Dayem, Soha M ^a   Battah, Ahmed A ^b   Soliman, Randa A ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Cardiac autonomic neuropathy; Complications; Natural history; Type 1 diabetes

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; ARTICLE; AUTONOMIC NEUROPATHY; CARDIAC AUTONOMIC NEUROPATHY; CARDIOVASCULAR REFLEX; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DETERIORATION; DISEASE COURSE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREVALENCE; PROSPECTIVE STUDY; REMISSION; SCHOOL CHILD; VOLUNTEER;

EID: 79956290732     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2011.061     Document Type: Article

References (25)

1. Vinik AI, Erbas T. Neuropathy. In: Ruderman N, Devlin JT, Schneider SH, Kriska A, editors. Handbook of Exercise in Diabetes. 2nd ed. Alexandria: American Diabetes Association, 2002.p. 463-96.
2. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003; 26: 1553-79.
3. Veglio M, Chinaglia A, Cavallo-Perin P. QT interval, cardiovascular risk factors and risk of death in diabetes. J Endocrinol Invest 2004; 27: 175-81.
4. Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care 2006; 29: 334-9.
5. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. All cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from UK general practice research database 1992-1999. Diabetologia 2006; 49: 660-6.
6. Lacigova S, Bartunek L, Cechurova D, Visek J, Gruberova J, Krcma M, et al. Influence of cardiovascular autonomic neuropathy on atherogenesis and heart function in patients with type 1 diabetes. Diabetes Res Clin Pract 2009; 83: 26-31.
7. Foss-Freitas MC, Margus Junior W, Foss MC. Autonomic Neuropathy: A High Risk Complication for Type 1 Diabetes Mellitus. Arq Bras Endocrinol Metabol 2008; 52: 398-406.
8. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985; 8: 491-8.
9. Consensus Statement. Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy. American Diabetes Association American Academy of Neurology. Diabetes Care 1988; 11: 592-7.
10. Trivelli LA, Ranney HM, Lai HT. Hemoglobin components in patients with diabetes mellitus. N Engl J Med 1971; 284: 353-7.
11. Valensi P, Pariès J, Attali JR; French Group for Research and Study of Diabetic Neuropathy. Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications-the French multicenter study. Metabolism 2003; 52: 815-20.
12. Pavy-Le Traon A, Fontaine S, Tap G, Guidolin B, Senard JM, Hanaire H. Cardiovascular autonomic neuropathy and other complications in type 1 diabetes. Clin Auton Res 2010; 20: 153-60.
13. Aman J, Eriksson E, Lideen J. Autonomic nerve function in children and adolescents with insulin-dependent diabetes mellitus. Clin Physiol 1991; 11: 537-43.
14. Khoharo HK, Ansari S, Ali Shaikh I, Qureshi F. Cardiac autonomic neuropathy (CAN) in type-1 diabetes mellitus patients and its association with the duration of disease and glycemic control. J Coll Physicians Surg Pak 2009; 4: 232-5.
15. Ducher M, Bertram D, Sagnol I, Cerutti C, Thivolet C, Fauvel JP. Limits of clinical tests to screen autonomic function in diabetes type I. Diabetes Metab 2001; 27: 545-50.
16. Jideh B, Jelinek HF. Identifying diabetic autonomic neuropathy from heart rate variability. Proceedings of The Australian Health and Medical Research Congress: 22-26 November 2004; Sydney, Australia. 2004. p. 234.
17. Khandoker AH, Jelinek HF, Palaniswami M. Identifying diabetic patients with cardiac autonomic neuropathy by heart rate complexity analysis. Biomed Eng Online 2009; 8: 3.
18. Karamitsos DT, Didangelos TP, Athyros VG, Kontopoulos AG. The natural history of recently diagnosed autonomic neuropathy over a period of 2 years, Diabetes Res Clin Pract 1998; 42: 55-63.
19. Scarmuzza A, Salvucci F, Leuzzi S, Radaelli A, d'Annunzio G, Fratino P, et al. Cardiovascular autonomic testing in adolescents with type I (insulin dependent) diabetes mellitus: an 18-month follow up study. Clin Sci (Lond) 1998; 94: 615-21.
20. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007; 115: 387-97.
21. Larsen JR, Sjoholm H, Berg TJ, Sandvik L, Brekke M, Hassen KF, et al. Eighteen years of fair glycemic control preserves cardiac autonomic function in type 1 diabetes. Diabetes Care 2004; 27: 963-6.
22. Schmid H. Cardiovascular impact of the autonomic neuropathy of diabetes mellitus. Arq Bras Endocrinol Metabol 2007; 51: 232-43.
23. Stettler C, Bearth A, Allemann S, Zwahlen M, Zanchin L, Deplazes M, et al. QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up. Diabetologia 2007; 50: 186-94.
24. Pappachan JM, Sebastian J, Bino BC, Jayaprakash K, Vijayakumar K, Sujathan P, et al. Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis. Postgrad Med J 2008; 84: 205-10.
25. Salem M, El Behery S, Adly A, Khalil D, El Hadidi E. Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 2009; 10: 513-21.